Influenza Clinical Diagnostic Testing and Antiviral Treatment among Children Hospitalized with Acute Respiratory Illness During the 2015–16 Influenza Season

1164. Influenza Clinical Diagnostic Testing and Antiviral Treatment among Children Hospitalized with Acute Respiratory Illness During the 2015–16 Influenza Season Angela P. Campbell, MD, MPH, FPIDS, FIDSA; Craig McGowan, MS; Brian Rha, MD, MSPH; Julie A. Boom, MD; Janet Englund, MD, FIDSA; Natasha B. Halasa, MD, MPH, FPIDS; Rangaraj Selvarangan, PhD; Mary A. Staat, MD, MPH; Geoffrey A. Weinberg, MD, FIDSA, FPIDS; Parvin H. Azimi, MD; Eileen J. Klein, MD, MPH; Monica McNeal, MS; Leila C. Sahni, MPH; Monica N. Singer, MD, MPH; Laura Stewart, PhD; Peter G. Szilagyi, MD, MPH; Christopher J. Harrison, MD, FAAP, FPIDS; Daniel C. Payne, PhD, MSPH and Alicia M. Fry, MD, MPH; Influenza Division, Centers for Disease Control and Prevention, Atlanta, Georgia, Division of Viral Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia, Texas Children’s Hospital, Houston, Texas, University of Washington/ Seattle Children’s Hospital, Seattle, Washington, Vanderbilt University School of Medicine, Nashville, Tennessee, Children’s Mercy Hospital and Clinics, Kansas City, Missouri, Cincinnati Children’s Hospital Medical Center, Cincinnati, Ohio, University of Rochester Sch. of Medicine and Dentistry, Rochester, New York, UCSF Benioff Children’s Hospital Oakland, Oakland, California, University of California at Los Angeles, Los Angeles, California